#70 Influence of predictive features on therapy response and survival in high-grade serous ovarian cancer patients by germline BRCA mutation status: an update from the australian ovarian cancer study

Tibor A Zwimpfer,Sian Fereday,Dinuka Ariyaratne,Laura Twomey,Nadia Traficante,Ellen L Goode,Anna Defazio,David Dl Bowtell,Dale W Garsed

doi:10.1136/ijgc-2023-esgo.56

#70 Influence of predictive features on therapy response and survival in high-grade serous ovarian cancer patients by germline BRCA mutation status: an update from the australian ovarian cancer study

Tibor A Zwimpfer, Sian Fereday + Show 7 more

Open Access

https://doi.org/10.1136/ijgc-2023-esgo.56

Copy DOI

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society	Publication Date: Sep 1, 2023
Citations: 1	License type: other-oa

Affiliation: University Hospital of Basel, Peter MacCallum Cancer Centre, University of Melbourne, Mayo Clinic, Westmead Hospital, University of Sydney

#High-grade Serous Ovarian Cancer #Australian Ovarian Cancer Study + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Introduction/BackgroundPathogenic germline BRCA1 and BRCA2 (BRCA) variants are frequent in high-grade serous ovarian cancer (HGSOC). Age, tumor stage, and residual disease are known predictors of survival. However, it is not...

Full Text